Open Access Open Access  Restricted Access Subscription or Fee Access

Uses of Biomaterials and Biocompatible Materials

Jaya Mishra

Abstract


Biomaterial evolution is not an innovative study field; it has been heading on for approximately half - century. Biomaterial science is the restraint that concentrates on the research of biomaterials. It is a highly contested discipline of science that has witnessed sustained, robust growth over the span of its existence. Many businesses have made considerable financial investments in the innovation of fresh products. The disciplines of biology, chemistry, engineering of tissues, and materials science are all incorporated into biomaterial science. Biomaterials are substances established with the specific intent of engaging with biological systems. All such components are bioactive and easily accumulate to human tissue. Through terms of biodegradability, they accomplish well. They are commonly implemented in design and manufacturing for pharmaceuticals, organ transplantation, the generation of body segments, and other disciplines. Integrated cutting-edge production system into the creation of innovative sustainable materials is endorsed by the simultaneous occurrence of sustainability and biomaterials. Efficient and environmentally biomaterials are used. Either green marketing is used to fabricate them or they are derived from varied biochemical resources. Many biomaterials have been developed and examined to date as potential substitutes for traditional techniques. These components have been skill fully employed in a diverse selection of biomedical fields. Prospective attributes and uses are extensively highlighted.

Full Text:

PDF

References


Chen Q, Thouas GA. Metallic implant biomaterials. Materials Science and Engineering: R: Reports. 2015; 87:1-57.

Patel NR, Gohil PP. A review on biomaterials: scope, applications & human anatomy significance. International Journal of Emerging Technology and Advanced Engineering.2012;2(4):91-101.

Davis JR. Overview of biomaterials and their use in medical devices. Handbook of materials for medical devices. 2003:1-1.

Navarro M, Michiardi A, Castano O, Planell JA. Biomaterials in orthopaedics. Journal of the royal society interface. 2008;5(27):1137-58.

Thorne SH, Negrin RS, Contag CH. Synergistic antitumor effects of immune cell-viral biotherapy. Science. 2006;311(5768):1780-4.

Gretch D. Editorial commentary: advocating the concept of GB virus C biotherapy against AIDS. Clinical infectious diseases. 2012;55(7):1020-1.

Naji A, Rouas-Freiss N, Durrbach A, Carosella ED, Sensébé L, Deschaseaux F. Concise review:combining human leukocyte antigen G and mesenchymal stem cells for immunosuppressant biotherapy. Stem cells. 2013 ;31(11):2296-303

Van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nature reviews Drug discovery. 2012;11(11):860-72.

Jieheng W, Angang Y, Weihong W. Current status of bench-to-bedside translation of cancer therapeutic antibodies. Chinese Journal of Cancer Biotherapy. 2014;21(3):325-33.

Abdelbary H, Brown CW, Werier J, Bell J. Using targeted virotherapy to treat a resistant Ewing sarcoma model: From the bedside to the bench and back. The Scientific World Journal. 2014;2014.

Uckun FM. Monoclonal Antibody (mAb)-Based Biotherapy Options for B-lineage Non-Hodgkin’s Lymphoma (NHL). Transl Med 3: e118. doi: 10.4172/2161-1025.1000 e118 Page 2 of 2

Radioimmunotherapy and anti-CD20 immunotherapy in non-Hodgkin lymphom a (NHL): Phase I results. In54th ASH Annual Meeting, San Diego, CA, Abstrac 2013 (Vol. 3680, p. 12).

Chen X, Lin X, Zhao J, Shi W, Zhang H, Wang Y, Kan B, Du L, Wang B, Wei Y, Liu Y. A tumorselective biotherapy with prolonged impact on established metastases based on cytokine geneengineered MSCs. Molecular Therapy. 2008;16(4):749-56.

Su X, Zhang L, Jin L, Ye J, Guan Z, Chen R, Guo T. Immunotherapy with cytokine-induced killer cells in metastatic renal cell carcinoma. Cancer biotherapy & radiopharmaceuticals.

;25(4):465-70.

Niidome T, Huang L. Gene therapy progress and prospects: nonviral vectors. Gene therapy. 2002Dec;9(24):1647-52.

Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature. 2001;411(6835):380-4.

Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature. 2008 Feb;451(7181):937-42.

Huang X, Liu D, Liu K et al 2006 Haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion for the treatment of hematological malignancies Bone Marrow Transpl. 8

-7


Refbacks

  • There are currently no refbacks.